City

Toronto (1)

Condition

Fallopian Tube Cancer (1)

High Grade Endometrioid Cancer (1)

High Grade Serous Cancer (1)

Ovarian Cancer (1)

Primary Peritoneal Cancer (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

University Health Network, Toronto (1)

Collaborator

GlaxoSmithKline (1)

Intervention

bevacizumab (1)

dostarlimab (1)

niraparib (1)

paclitaxel (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

high grade serous cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Toronto (Niraparib, Dostarlimab, Bevacizumab)

Not yet recruiting

Ovarian Cancer
+4 more

Niraparib
+3 more

Toronto, Ontario, Canada

Princess Margaret Cancer Centre

May 2, 2022